Mottiwala Aziz Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$1.49M

Insider Activity of Mottiwala Aziz

According to the SEC Form 4 filings, Mottiwala Aziz, being in a position of

  1. Chief Commercial Officer at Tarsus Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 13056 shares for $892,528,
    over all time since 2021-09-10, has bought 0 shares, and sold 83184 shares for $3.15M.

Biography of Mottiwala Aziz

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $892,5283100

Comparison of Insiders on Amount of Buys and Sells

2026-03-19SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
4,440
0.0105%
$67.00$297,480+0.38%
2026-03-18SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
4,330
0.0102%
$68.71$297,514-1.88%
2026-03-17SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
4,286
0.01%
$69.42$297,534-3.99%
2025-06-09SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
17,500
0.0423%
$43.76$765,800+50.87%
2025-03-20SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
3,365
0.0082%
$50.11$168,620+15.47%
2025-03-19SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
3,557
0.0083%
$47.40$168,602+15.9%
2025-03-18SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
3,643
0.0089%
$46.29$168,634+24.19%
2024-03-18SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
4,766
0.0127%
$30.60$145,840+17.17%
2023-07-19SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
2,400
0.0089%
$20.05$48,120+20.86%
2023-06-08SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
100
0.0004%
$20.00$2,000-2.45%
2023-06-07SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
2,500
0.0095%
$19.34$48,350+1.41%
2023-06-06SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
2,143
0.0079%
$18.61$39,881+1.89%
2023-03-23SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
372
0.0014%
$12.15$4,520+42.92%
2023-03-22SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
357
0.0014%
$12.64$4,512+44.02%
2023-03-21SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
349
0.0013%
$12.89$4,499+34.3%
2023-03-20SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
358
0.0013%
$12.61$4,514+32.64%
2023-03-17SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
339
0.0013%
$13.28$4,502+35.57%
2023-03-16SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
336
0.0013%
$13.43$4,512+28.76%
2022-11-15SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
6,857
0.0277%
$17.72$121,506-10.11%
2021-11-08SaleTarsus Pharmaceuticals, Inc.
TARS
Chief Commercial Officer
3,778
0.0184%
$28.11$106,200-38.57%
Total: 24
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.